Dendritic cells fused with different pancreatic carcinoma cells induce different T-cell responses

References

• StiftAFriedlJDubskyPDendritic cell-based vaccination in solid cancerJ Clin Oncol200321113514212506182
   PubMed Web of Science ®Google Scholar
• NakamuraMWadaJSuzukiHTanakaMKatanoMMorisakiTLong-term outcome of immunotherapy for patients with refractory pancreatic cancerAnticancer Res200929383183619414316
   PubMed Web of Science ®Google Scholar
• SusoEMDuelandSRasmussenAMhTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopesCancer Immunol Immunother201160680981821365467
   PubMed Web of Science ®Google Scholar
• BauerCDauerMSarajSDendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot studyCancer Immunol Immunother20116081097110721547597
   PubMed Web of Science ®Google Scholar
• NakamuraIKanazawaMSatoYClinical evaluation of dendritic cells vaccination for advanced cancer patients at Fukushima Medical UniversityFukushima J Med Sci2012581404822790891
   PubMedGoogle Scholar
• PecherGHäringAKaiserLThielEMucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trialCancer Immunol Immunother20025111–1266967312439613
   PubMed Web of Science ®Google Scholar
• NagarajSZiskeCStrehlJMessmerDSauerbruchTSchmidt-WolfIGDendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivoInt Immunol20061881279128316772371
   PubMed Web of Science ®Google Scholar
• NagarajSNeumannJWinzenBPancreas carcinoma antigen fused to invariant chain elicits T-cell response and tumor growth inhibitionPancreas200837332132718815556
   PubMed Web of Science ®Google Scholar
• LepistoAJMoserAJZehHA phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumorsCancer Ther20086B95596419129927
   PubMedGoogle Scholar
• BéraudECollignonAFranceschiCOliveDLombardoDMasEInvestigation of a new tumor-associated glycosylated antigen as target for dendritic cell vaccination in pancreatic cancerOncoimmunology201211566122720212
   PubMed Web of Science ®Google Scholar
• HirookaYItohAKawashimaHA combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancerPancreas2009383e69e7419276867
   PubMed Web of Science ®Google Scholar
• BauerCBauernfeindFSterzikADendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma modelGut20075691275128217395611
   PubMed Web of Science ®Google Scholar
• DauerMHertenJBauerCChemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cellsJ Immunother200528433234216000951
   PubMed Web of Science ®Google Scholar
• BanchereauJPaluckaAKDhodapkarMImmune and clinical responses in patients with metastatic melanoma to CD34+ progenitor-derived dendritic cell vaccineCancer Res200161176451645811522640
   PubMed Web of Science ®Google Scholar
• BoghossianSRobinsonSVon DelwigAManasDWhiteSImmunotherapy for treating metastatic colorectal cancerSurg Oncol2012212677721292476
   PubMed Web of Science ®Google Scholar
• AviganDRosenblattJKufeDDendritic/tumor fusion cells as cancer vaccinesSemin Oncol201239328729522595051
   PubMed Web of Science ®Google Scholar
• XuFYeYJLiuWKongMHeYWangSDendritic cell/tumor hybrids enhances therapeutic efficacy against colorectal cancer liver metastasis in SCID miceScand J Gastroenterol201045670771320205622
   PubMed Web of Science ®Google Scholar
• SadunRESachsmanSMChenXImmune signatures of murine and human cancers reveal unique mechanisms of tumor escape and new targets for cancer immunotherapyClin Cancer Res200713134016402517606736
   PubMed Web of Science ®Google Scholar
• LeDTJaffeeEMRegulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspectiveCancer Res201272143439344422761338
   PubMed Web of Science ®Google Scholar
• SchmidtAOberleNKrammerPHMolecular mechanisms of tregmediated T cell suppressionFront Immunol201235122566933
   PubMed Web of Science ®Google Scholar
• RaynorJLagesCSShehataHHildemanDAChougnetCAHomeostasis and function of regulatory T cells in agingCurr Opin Immunol201224448248722560294
   PubMed Web of Science ®Google Scholar
• FacciabeneAMotzGTCoukosGT-regulatory cells: key players in tumor immune escape and angiogenesisCancer Res20127292162217122549946
   PubMed Web of Science ®Google Scholar
• BaratelliFLinYZhuLProstaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cellsJ Immunol200517531483149016034085
   PubMed Web of Science ®Google Scholar
• LeaoICGanesanPArmstrongTDJaffeeEMEffective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinomaClin Transl Sci20081322823920357913
   PubMed Web of Science ®Google Scholar
• ZiskeCEtzrodtPEEliuASIncrease of in vivo antitumoral activity by CD40L (CD154) gene transfer into pancreatic tumor celldendritic cell hybridsPancreas200938775876519546834
   PubMed Web of Science ®Google Scholar
• NagarajSNeumannJWinzenBPancreas carcinoma antigen fused to invariant chain elicits T-cell response and tumor growth inhibitionPancreas200837332132718815556
   PubMed Web of Science ®Google Scholar
• NagarajSZiskeCStrehlJMessmerDSauerbruchTSchmidt-WolfIGDendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivoInt Immunol20061881279128316772371
   PubMed Web of Science ®Google Scholar
• MaddenMESarrasMPJrMorphological and biochemical characterization of a human pancreatic ductal cell line (PANC-1)Pancreas1988355125283141917
   PubMed Web of Science ®Google Scholar
• FunakoshiAKonoAGrowth inhibition of human pancreatic cancer cells by cholecystokinin receptor antagonist in tissue culture and in nude miceGastroenterol Jpn199227178821555749
   PubMedGoogle Scholar
• KakuMNishiyamaTYagawaKAbeMEstablishment of a carcinoembryonic antigen-producing cell line from human pancreatic carcinomaGann19807155966017227711
   PubMedGoogle Scholar
• IkedaYEzakiMHayashiIYasudaDNakayamaKKonoAEstablishment and characterization of human pancreatic cancer cell lines in tissue culture and in nude miceJpn J Cancer Res199081109879932172194
   PubMedGoogle Scholar
• RamosRNChinLSDos SantosAPBergami-SantosPCLaginhaFBarbutoJAMonocyte-derived dendritic cells from breast cancer patients are biased to induce CD4+CD25+Foxp3+ regulatory T cellsJ Leukoc Biol201292367368222636320
   PubMed Web of Science ®Google Scholar
• GongJNikruiNChenDFusions of human ovarian carcinoma cells autologous or allogenic dendritic cells induce antitumor immunityJ Immunol200016531705171110903782
   PubMed Web of Science ®Google Scholar
• IwashitaYGotoSTominagaMDendritic cell immunotherapy with poly(D,L-2,4-diaminobutyric acid)-mediated intratumoral delivery of the interleukin-12 gene suppresses tumor growth significantlyCancer Sci200595530330715904472
   PubMed Web of Science ®Google Scholar
• TakahashiKHiranoFMatsumotoKAsoKHanedaMHomeobox gene CDX2 inhibits human pancreatic cancer cell proliferation by down-regulating cyclin D1 transcriptional activityPancreas2009381495719106744
   PubMed Web of Science ®Google Scholar
• ShengKCWrightMDApostolopoulosVInfammatory mediators hold the key to dendritic cell suppression and tumor progressionCurr Med Chem201118365507551822172061
   PubMed Web of Science ®Google Scholar
• BernalMRuiz-CabelloFConchaAPaschenAGarridoFImplication of the β2-microglobulin gene in the generation of tumor escape phenotypesCancer Immunol Immunother20126191359137122833104
   PubMed Web of Science ®Google Scholar
• KasuyaKNagakawaYSuzukiMAnti-vascular endothelial growth factor antibody single therapy for pancreatic neuroendocrine carcinoma exhibits a marked tumor growth-inhibitory effectExp Ther Med2011261047105222977618
   PubMed Web of Science ®Google Scholar
• UrryZChambersESXystrakisEThe role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+CD4+ T cellsEur J Immunol201242102697270822903229
   PubMed Web of Science ®Google Scholar
• LevingsMKGregoriSTresoldiECazzanigaSBoniniCRoncaroloMGDifferentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cellsBlood200510531162116915479730
   PubMed Web of Science ®Google Scholar
• YamamotoMKamigakiTYamashitaKEnhancement of antitumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancerOncol Rep200922233734319578774
   PubMed Web of Science ®Google Scholar
• MaksimowMMiiluniemiMMarttila-IchiharaFJalkanenSHänninenAAntigen targeting to endosomal pathway in dendritic cell vaccination activates regulatory T cells and attenuates tumor immunityBlood200610841298130516621963
   PubMed Web of Science ®Google Scholar
• EhehaltFSaegerHDSchmidtCMGrützmannRNeuroendocrine tumors of the pancreasOncologist200914545646719411317
   PubMed Web of Science ®Google Scholar
• SchottMFieldkampJLettmannMSimonDScherbaumWASeisslerJDendritic cell immunotherapy in a neuroendocrine pancreas carcinomaClin Endocrinol2001552271277
   PubMed Web of Science ®Google Scholar